170 related articles for article (PubMed ID: 36848686)
1. CYP102A1 peroxygenase catalyzed reaction via in situ H
Hardiyanti Oktavia FAR; Nguyen NA; Park CM; Cha GS; Nguyen THH; Yun CH
J Inorg Biochem; 2023 May; 242():112165. PubMed ID: 36848686
[TBL] [Abstract][Full Text] [Related]
2. Selective carbon-hydrogen bond hydroxylation using an engineered cytochrome P450 peroxygenase.
Akter J; Stockdale TP; Child SA; Lee JHZ; De Voss JJ; Bell SG
J Inorg Biochem; 2023 Jul; 244():112209. PubMed ID: 37080140
[TBL] [Abstract][Full Text] [Related]
3. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
[TBL] [Abstract][Full Text] [Related]
4. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
5. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
6. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3.
Kim DH; Ahn T; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2009 May; 37(5):932-6. PubMed ID: 19237510
[TBL] [Abstract][Full Text] [Related]
7. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
[TBL] [Abstract][Full Text] [Related]
8. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
[TBL] [Abstract][Full Text] [Related]
9. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
[TBL] [Abstract][Full Text] [Related]
10. Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite.
Jang HH; Ryu SH; Le TK; Doan TT; Nguyen TH; Park KD; Yim DE; Kim DH; Kang CK; Ahn T; Kang HS; Yun CH
Biotechnol Lett; 2017 Jan; 39(1):105-112. PubMed ID: 27640009
[TBL] [Abstract][Full Text] [Related]
11. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the cytochrome P450 peroxygenase enzymes.
Munro AW; McLean KJ; Grant JL; Makris TM
Biochem Soc Trans; 2018 Feb; 46(1):183-196. PubMed ID: 29432141
[TBL] [Abstract][Full Text] [Related]
13. Emerging Strategies for Modifying Cytochrome P450 Monooxygenases into Peroxizymes.
Fan S; Cong Z
Acc Chem Res; 2024 Jan; ():. PubMed ID: 38293787
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
Yuan X; Wang Q; Horner JH; Sheng X; Newcomb M
Biochemistry; 2009 Sep; 48(38):9140-6. PubMed ID: 19708688
[TBL] [Abstract][Full Text] [Related]
15. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous detection of NADPH consumption and H
Morlock LK; Böttcher D; Bornscheuer UT
Appl Microbiol Biotechnol; 2018 Jan; 102(2):985-994. PubMed ID: 29150709
[TBL] [Abstract][Full Text] [Related]
17. Analysis of critical residues for peroxygenation and improved peroxygenase activity via
Pardhe BD; Oh TJ
Front Microbiol; 2023; 14():1296202. PubMed ID: 38149268
[TBL] [Abstract][Full Text] [Related]
18. The relationships between cytochromes P450 and H
Albertolle ME; Peter Guengerich F
J Inorg Biochem; 2018 Sep; 186():228-234. PubMed ID: 29990746
[TBL] [Abstract][Full Text] [Related]
19. Multienzymatic in situ hydrogen peroxide generation cascade for peroxygenase-catalysed oxyfunctionalisation reactions.
Pesic M; Willot SJ; Fernández-Fueyo E; Tieves F; Alcalde M; Hollmann F
Z Naturforsch C J Biosci; 2019 Feb; 74(3-4):101-104. PubMed ID: 30379645
[TBL] [Abstract][Full Text] [Related]
20. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Cha GS; Ryu SH; Ahn T; Yun CH
Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
